Where are we on the global health pandemic? What are the key drivers that affect pandemic outcomes in different markets? Long COVID – What will be the longer-term mortality and morbidity effects?

Adam Strange, Life & health R&D analyst, Swiss Re

MODERATOR: Colin Tate AM, Chief executive officer, Conexus Financial

Join the discussion